APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Receptor Tyrosine Protein Kinase TYK2

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Non Receptor Tyrosine Protein Kinase TYK2 Market Analysis and Forecast 2026-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchNon Receptor Tyrosine Protein Kinase TYK2 Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Receptor Tyrosine Protein Kinase TYK2 Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Receptor Tyrosine Protein Kinase TYK2 Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Non Receptor Tyrosine Protein Kinase TYK2 market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Non Receptor Tyrosine Protein Kinase TYK2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Non Receptor Tyrosine Protein Kinase TYK2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Non Receptor Tyrosine Protein Kinase TYK2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Non Receptor Tyrosine Protein Kinase TYK2 is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Non Receptor Tyrosine Protein Kinase TYK2 include Takeda Pharmaceutical Company Ltd, Pfizer Inc, Bristol-Myers Squibb Company, Theravance Biopharma Inc, Sareum Holdings Plc, Portola Pharmaceuticals Inc, Nimbus Therapeutics LLC and Array BioPharma Inc, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Non Receptor Tyrosine Protein Kinase TYK2, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Non Receptor Tyrosine Protein Kinase TYK2, also provides the sales of main regions and countries. Of the upcoming market potential for Non Receptor Tyrosine Protein Kinase TYK2, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non Receptor Tyrosine Protein Kinase TYK2 sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Non Receptor Tyrosine Protein Kinase TYK2 market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Non Receptor Tyrosine Protein Kinase TYK2 sales, projected growth trends, production technology, application and end-user industry.

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Company

Takeda Pharmaceutical Company Ltd

Pfizer Inc

Bristol-Myers Squibb Company

Theravance Biopharma Inc

Sareum Holdings Plc

Portola Pharmaceuticals Inc

Nimbus Therapeutics LLC

Array BioPharma Inc

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Type

ARRY-624

BMS-986165

NDI-031232

Cerdulatinib

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Application

Follicular Lymphoma

Lupus Nephritis

Hypersensitivity

Marginal Zone B-cell Lymphoma

Others

Non Receptor Tyrosine Protein Kinase TYK2 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Receptor Tyrosine Protein Kinase TYK2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Receptor Tyrosine Protein Kinase TYK2 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Receptor Tyrosine Protein Kinase TYK2.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Non Receptor Tyrosine Protein Kinase TYK2 in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Non Receptor Tyrosine Protein Kinase TYK2 manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Non Receptor Tyrosine Protein Kinase TYK2 sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. ARRY-624 Major Manufacturers Table 3. BMS-986165 Major Manufacturers Table 4. NDI-031232 Major Manufacturers Table 5. Cerdulatinib Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Follicular Lymphoma Major Manufacturers Table 9. Lupus Nephritis Major Manufacturers Table 10. Hypersensitivity Major Manufacturers Table 11. Marginal Zone B-cell Lymphoma Major Manufacturers Table 12. Others Major Manufacturers Table 13. Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends Table 14. Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers Table 15. Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges Table 16. Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints Table 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2026) Table 21. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2027-2032) Table 22. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026) & (K Units) Table 24. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2027-2032) & (K Units) Table 25. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2026) Table 26. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2027-2032) Table 27. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Manufacturers (2021-2026) Table 31. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 32. Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers, Product Type & Application Table 35. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Non Receptor Tyrosine Protein Kinase TYK2 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2026) Table 42. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2027-2032) Table 43. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 44. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 45. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 46. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2026) Table 47. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2027-2032) Table 48. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2026) & (US$/Unit) Table 49. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2027-2032) & (US$/Unit) Table 50. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2026) Table 54. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2027-2032) Table 55. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 56. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 57. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 58. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2026) Table 59. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2027-2032) Table 60. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2026) & (US$/Unit) Table 61. Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2027-2032) & (US$/Unit) Table 62. Takeda Pharmaceutical Company Ltd Company Information Table 63. Takeda Pharmaceutical Company Ltd Business Overview Table 64. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 66. Takeda Pharmaceutical Company Ltd Recent Development Table 67. Pfizer Inc Company Information Table 68. Pfizer Inc Business Overview Table 69. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 71. Pfizer Inc Recent Development Table 72. Bristol-Myers Squibb Company Company Information Table 73. Bristol-Myers Squibb Company Business Overview Table 74. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 76. Bristol-Myers Squibb Company Recent Development Table 77. Theravance Biopharma Inc Company Information Table 78. Theravance Biopharma Inc Business Overview Table 79. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 81. Theravance Biopharma Inc Recent Development Table 82. Sareum Holdings Plc Company Information Table 83. Sareum Holdings Plc Business Overview Table 84. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 86. Sareum Holdings Plc Recent Development Table 87. Portola Pharmaceuticals Inc Company Information Table 88. Portola Pharmaceuticals Inc Business Overview Table 89. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 91. Portola Pharmaceuticals Inc Recent Development Table 92. Nimbus Therapeutics LLC Company Information Table 93. Nimbus Therapeutics LLC Business Overview Table 94. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 96. Nimbus Therapeutics LLC Recent Development Table 97. Array BioPharma Inc Company Information Table 98. Array BioPharma Inc Business Overview Table 99. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio Table 101. Array BioPharma Inc Recent Development Table 102. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 105. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 106. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2021-2026) & (US$/Unit) Table 107. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2027-2032) & (US$/Unit) Table 108. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 111. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 112. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2021-2026) & (US$/Unit) Table 113. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2027-2032) & (US$/Unit) Table 114. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 118. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 119. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 120. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2021-2026) & (US$/Unit) Table 121. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2027-2032) & (US$/Unit) Table 122. United States Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 123. Canada Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 124. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 127. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 128. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2021-2026) & (US$/Unit) Table 129. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2027-2032) & (US$/Unit) Table 130. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 133. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 134. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2021-2026) & (US$/Unit) Table 135. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2027-2032) & (US$/Unit) Table 136. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 140. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 141. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 142. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2021-2026) & (US$/Unit) Table 143. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2027-2032) & (US$/Unit) Table 144. Germany Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 145. France Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 146. U.K. Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 147. Italy Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 148. Netherlands Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 149. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 150. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 151. China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 152. China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 153. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2021-2026) & (US$/Unit) Table 154. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2027-2032) & (US$/Unit) Table 155. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 156. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 157. China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 158. China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 159. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2021-2026) & (US$/Unit) Table 160. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 162. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 163. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 164. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 165. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2021-2026) & (US$/Unit) Table 166. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2027-2032) & (US$/Unit) Table 167. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 168. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 169. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 170. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 171. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2021-2026) & (US$/Unit) Table 172. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2027-2032) & (US$/Unit) Table 173. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 174. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 175. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 176. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 177. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 178. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 179. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2021-2026) & (US$/Unit) Table 180. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2027-2032) & (US$/Unit) Table 181. Japan Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 182. South Korea Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 183. India Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 184. Australia Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 185. China Taiwan Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 186. Southeast Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 187. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2026) & (US$ Million) Table 188. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2027-2032) & (US$ Million) Table 189. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2026) & (K Units) Table 190. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2027-2032) & (K Units) Table 191. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2021-2026) & (US$/Unit) Table 192. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Type (2027-2032) & (US$/Unit) Table 193. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2026) & (US$ Million) Table 194. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2027-2032) & (US$ Million) Table 195. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2026) & (K Units) Table 196. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2027-2032) & (K Units) Table 197. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2021-2026) & (US$/Unit) Table 198. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Application (2027-2032) & (US$/Unit) Table 199. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 200. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 201. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 202. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 203. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021-2026) & (K Units) Table 204. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2027-2032) & (K Units) Table 205. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2021-2026) & (US$/Unit) Table 206. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Country (2027-2032) & (US$/Unit) Table 207. Brazil Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 208. Argentina Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 209. Chile Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 210. Colombia Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 211. Peru Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 212. Saudi Arabia Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 213. Israel Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 214. UAE Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 215. Turkey Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 216. Iran Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 217. Egypt Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Table 218. Key Raw Materials Table 219. Raw Materials Key Suppliers Table 220. Non Receptor Tyrosine Protein Kinase TYK2 Distributors List Table 221. Non Receptor Tyrosine Protein Kinase TYK2 Customers List Table 222. Research Programs/Design for This Report Table 223. Authors List of This Report Table 224. Secondary Sources Table 225. Primary Sources List of Figures Figure 1. Non Receptor Tyrosine Protein Kinase TYK2 Image Figure 2. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Share 2021 VS 2025 VS 2032 Figure 4. ARRY-624 Image Figure 5. BMS-986165 Image Figure 6. NDI-031232 Image Figure 7. Cerdulatinib Image Figure 8. Others Image Figure 9. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size Share 2021 VS 2025 VS 2032 Figure 11. Follicular Lymphoma Image Figure 12. Lupus Nephritis Image Figure 13. Hypersensitivity Image Figure 14. Marginal Zone B-cell Lymphoma Image Figure 15. Others Image Figure 16. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue (2021-2032) & (US$ Million) Figure 18. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2032) Figure 21. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales (2021-2032) & (K Units) Figure 22. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 23. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Non Receptor Tyrosine Protein Kinase TYK2 Sales YoY (2021-2032) & (K Units) Figure 25. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales YoY (2021-2032) & (K Units) Figure 26. China Non Receptor Tyrosine Protein Kinase TYK2 Sales YoY (2021-2032) & (K Units) Figure 27. Asia (Excluding China) Non Receptor Tyrosine Protein Kinase TYK2 Sales YoY (2021-2032) & (K Units) Figure 28. South America, Middle East and Africa Non Receptor Tyrosine Protein Kinase TYK2 Sales YoY (2021-2032) & (K Units) Figure 29. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032) Figure 35. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 36. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032) Figure 38. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032) Figure 41. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 42. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032) Figure 44. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Type (2021-2032) Figure 45. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Type (2021-2032) Figure 46. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Application (2021-2032) Figure 47. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Application (2021-2032) Figure 48. North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country (2021-2032) Figure 49. North America Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Country (2021-2032) Figure 50. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Type (2021-2032) Figure 51. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Type (2021-2032) Figure 52. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Application (2021-2032) Figure 53. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Application (2021-2032) Figure 54. Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country (2021-2032) Figure 55. Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Country (2021-2032) Figure 56. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Type (2021-2032) Figure 57. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Type (2021-2032) Figure 58. China Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Application (2021-2032) Figure 59. China Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Application (2021-2032) Figure 60. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Type (2021-2032) Figure 61. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Type (2021-2032) Figure 62. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Application (2021-2032) Figure 63. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Application (2021-2032) Figure 64. Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country (2021-2032) Figure 65. Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Country (2021-2032) Figure 66. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Type (2021-2032) Figure 67. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Type (2021-2032) Figure 68. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Application (2021-2032) Figure 69. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Application (2021-2032) Figure 70. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Share by Country (2021-2032) Figure 71. SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales Share by Country (2021-2032) Figure 72. Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • ARRY-624
  • BMS-986165
  • NDI-031232
  • Cerdulatinib
  • Others
Applications
  • Follicular Lymphoma
  • Lupus Nephritis
  • Hypersensitivity
  • Marginal Zone B-cell Lymphoma
  • Others
Companies covered
  • Takeda Pharmaceutical Company Ltd
  • Pfizer Inc
  • Bristol-Myers Squibb Company
  • Theravance Biopharma Inc
  • Sareum Holdings Plc
  • Portola Pharmaceuticals Inc
  • Nimbus Therapeutics LLC
  • Array BioPharma Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Non Receptor Tyrosine Protein Kinase TYK2 Market by Type
  3. 1.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 ARRY-624
  5. 1.2.3 BMS-986165
  6. 1.2.4 NDI-031232
  7. 1.2.5 Cerdulatinib
  8. 1.2.6 Others
  9. 1.3 Non Receptor Tyrosine Protein Kinase TYK2 Market by Application
  10. 1.3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Follicular Lymphoma
  12. 1.3.3 Lupus Nephritis
  13. 1.3.4 Hypersensitivity
  14. 1.3.5 Marginal Zone B-cell Lymphoma
  15. 1.3.6 Others
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Non Receptor Tyrosine Protein Kinase TYK2 Market Dynamics
  1. 2.1 Non Receptor Tyrosine Protein Kinase TYK2 Industry Trends
  2. 2.2 Non Receptor Tyrosine Protein Kinase TYK2 Industry Drivers
  3. 2.3 Non Receptor Tyrosine Protein Kinase TYK2 Industry Opportunities and Challenges
  4. 2.4 Non Receptor Tyrosine Protein Kinase TYK2 Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region
  3. 3.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2021-2026)
  5. 3.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Region (2027-2032)
  6. 3.2.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region
  9. 3.4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2021-2026)
  11. 3.4.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Region (2027-2032)
  12. 3.4.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers
  2. 4.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers
  6. 4.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Non Receptor Tyrosine Protein Kinase TYK2 Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers, Product Type & Application
  13. 4.7 Global Non Receptor Tyrosine Protein Kinase TYK2 Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Market CR5 and HHI
  16. 4.8.2 2025 Non Receptor Tyrosine Protein Kinase TYK2 Tier 1, Tier 2, and Tier 3
5 Non Receptor Tyrosine Protein Kinase TYK2 Market by Type
  1. 5.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type
  2. 5.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type
  6. 5.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Type (2021-2032)
  9. 5.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Type
6 Non Receptor Tyrosine Protein Kinase TYK2 Market by Application
  1. 6.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application
  2. 6.1.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application
  6. 6.2.1 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Sales Market Share by Application (2021-2032)
  9. 6.3 Global Non Receptor Tyrosine Protein Kinase TYK2 Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Company Ltd
  2. 7.1.1 Takeda Pharmaceutical Company Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Company Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Company Ltd Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Company Ltd Recent Developments
  7. 7.2 Pfizer Inc
  8. 7.2.1 Pfizer Inc Company Information
  9. 7.2.2 Pfizer Inc Business Overview
  10. 7.2.3 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  12. 7.2.5 Pfizer Inc Recent Developments
  13. 7.3 Bristol-Myers Squibb Company
  14. 7.3.1 Bristol-Myers Squibb Company Company Information
  15. 7.3.2 Bristol-Myers Squibb Company Business Overview
  16. 7.3.3 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Bristol-Myers Squibb Company Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  18. 7.3.5 Bristol-Myers Squibb Company Recent Developments
  19. 7.4 Theravance Biopharma Inc
  20. 7.4.1 Theravance Biopharma Inc Company Information
  21. 7.4.2 Theravance Biopharma Inc Business Overview
  22. 7.4.3 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Theravance Biopharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  24. 7.4.5 Theravance Biopharma Inc Recent Developments
  25. 7.5 Sareum Holdings Plc
  26. 7.5.1 Sareum Holdings Plc Company Information
  27. 7.5.2 Sareum Holdings Plc Business Overview
  28. 7.5.3 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sareum Holdings Plc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  30. 7.5.5 Sareum Holdings Plc Recent Developments
  31. 7.6 Portola Pharmaceuticals Inc
  32. 7.6.1 Portola Pharmaceuticals Inc Company Information
  33. 7.6.2 Portola Pharmaceuticals Inc Business Overview
  34. 7.6.3 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Portola Pharmaceuticals Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  36. 7.6.5 Portola Pharmaceuticals Inc Recent Developments
  37. 7.7 Nimbus Therapeutics LLC
  38. 7.7.1 Nimbus Therapeutics LLC Company Information
  39. 7.7.2 Nimbus Therapeutics LLC Business Overview
  40. 7.7.3 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Nimbus Therapeutics LLC Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  42. 7.7.5 Nimbus Therapeutics LLC Recent Developments
  43. 7.8 Array BioPharma Inc
  44. 7.8.1 Array BioPharma Inc Company Information
  45. 7.8.2 Array BioPharma Inc Business Overview
  46. 7.8.3 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Array BioPharma Inc Non Receptor Tyrosine Protein Kinase TYK2 Product Portfolio
  48. 7.8.5 Array BioPharma Inc Recent Developments
8 North America
  1. 8.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type
  2. 8.1.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  3. 8.1.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  4. 8.1.3 North America Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
  5. 8.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application
  6. 8.2.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  7. 8.2.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  8. 8.2.3 North America Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
  9. 8.3 North America Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country
  10. 8.3.1 North America Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Non Receptor Tyrosine Protein Kinase TYK2 Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type
  2. 9.1.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  3. 9.1.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  4. 9.1.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
  5. 9.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application
  6. 9.2.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  7. 9.2.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  8. 9.2.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
  9. 9.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country
  10. 9.3.1 Europe Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Non Receptor Tyrosine Protein Kinase TYK2 Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type
  2. 10.1.1 China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  3. 10.1.2 China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  4. 10.1.3 China Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
  5. 10.2 China Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application
  6. 10.2.1 China Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  7. 10.2.2 China Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  8. 10.2.3 China Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type
  2. 11.1.1 Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  3. 11.1.2 Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  4. 11.1.3 Asia Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
  5. 11.2 Asia Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application
  6. 11.2.1 Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  7. 11.2.2 Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  8. 11.2.3 Asia Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
  9. 11.3 Asia Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country
  10. 11.3.1 Asia Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Non Receptor Tyrosine Protein Kinase TYK2 Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Type
  2. 12.1.1 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Price by Type (2021-2032)
  5. 12.2 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Application
  6. 12.2.1 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Price by Application (2021-2032)
  9. 12.3 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Market Size by Country
  10. 12.3.1 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Non Receptor Tyrosine Protein Kinase TYK2 Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Non Receptor Tyrosine Protein Kinase TYK2 Value Chain Analysis
  2. 13.1.1 Non Receptor Tyrosine Protein Kinase TYK2 Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Non Receptor Tyrosine Protein Kinase TYK2 Production Mode & Process
  6. 13.2 Non Receptor Tyrosine Protein Kinase TYK2 Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Non Receptor Tyrosine Protein Kinase TYK2 Distributors
  9. 13.2.3 Non Receptor Tyrosine Protein Kinase TYK2 Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst